Pre-market · Regular session opens 9:30 AM ET
Last update: Nov 18, 2026, 6:18 PM ET

Trending Tickers

The stocks moving most, ranked by their latest session change — across all 986 companies we track. Click any ticker for the full change report.

986 stocks tracked
Most Active This Week
LQDA
Liquidia Corporation
$56.40▼ 0.58%
— · —
ValuationWhat changed:

Liquidia rallied 4.29% to $57.58 following a wave of analyst upgrades anchored by Raymond James' upgrade to Strong Buy with a $77 price target (raised from $53) and BTIG's hike to $87 (from $70), both citing robust Q3 results and resilient demand. Q3 revenues surged 314.9% year-over-year to $225.3M, driven by YUTREPIA pulmonary arterial hypertension drug sales of $222.7M, per Zacks earnings coverage. Volume of 523K shares remains below the 0.59x time-adjusted average.

🐻 Bearish — Score 40/100
View Full Report →
30D High
$56.73
30D Low
$33.94
30D Change
+66.18%
Risk Level
High

Most Significant Changes

Ranked by largest 1-day move

1
PSKYParamount Skydance Corporation Class B Common Stock
$9.77▲ 41.39%30D: +38.39%
High: $9.77Low: $6.91Risk: High
45 changes
No changes detected this week
2
HUMHumana Inc.
$385.78▼ 12.98%30D: -9.74%
High: $443.34Low: $385.78Risk: Low
65 changes
ValuationHumana shares fell 12.03% to $390.00 on regulatory and audit scrutiny targeting Medicare Advantage programs. The Centers for Medicare & Medicaid Services (CMS) announced plans to codify removal of a fee-for-service adjuster and extrapolate audit findings effective payment year 2018, with the rule due for Federal Register publication November 19, per web reports. A proposed federal fraud and waste rule also raised concerns over stricter reporting requirements and potential financial liability for Medicare Advantage insurers. The selloff is sector-wide: UnitedHealth Group, Elevance Health, Centene, and Molina Healthcare also declined, though Humana's 12% move is steeper. Volume reached 2.74M shares (2.06x time-adjusted average), reflecting elevated institutional repositioning.1d ago
3
OKTAOkta, Inc.
$195.61▲ 12.07%30D: -7.70%
High: $211.92Low: $174.54Risk: High
67 changes
Material / EarningsOkta, Inc. (OKTA) moved +9.90% from $177.99 to $195.61 on 2026-11-18. We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was found. The move occurred on elevated volume (2.3x the 5-day average), suggesting institutional interest, though the trigger remains unclear.1d ago
4
SAILSailPoint, Inc.
$22.25▲ 10.26%30D: +15.28%
High: $22.25Low: $19.30Risk: Medium
51 changes
No changes detected this week
5
UNHUnitedHealth Group Incorporated
$349.91▼ 10.21%30D: -11.55%
High: $395.62Low: $349.91Risk: High
74 changes
RiskUnitedHealth Group fell 6.95% to $362.61, declining nearly $27 per share on elevated volume (2.68x expected for this time of day). No major negative catalyst appeared in news flow; a UnitedHealthcare announcement on rural pharmacy access and commentary on 13–16% long-term earnings growth targets were published, but neither explains the sharp intraday drop. The selloff occurs amid broad market conditions and ahead of UNH's January 20 earnings release.1d ago
6
PANWPalo Alto Networks, Inc.
$339.92▲ 9.90%30D: -9.36%
High: $375.04Low: $309.29Risk: High
82 changes
ActivityPalo Alto Networks rose 8.22% to $334.72 ahead of its Q1 FY2027 earnings report (due after today's close), driven by a combination of heightened cybersecurity threat warnings and broader AI/tech momentum. Homeland Security Secretary Markwayne Mullin warned in congressional testimony of threats from Iranian-backed actors targeting U.S. financial, energy, and transportation systems, alongside AI-driven attack scaling, lifting demand for Palo Alto's Prisma AIRS platform and broader security solutions. Volume at 6.64M shares is 1.41x expected for this point in the session, consistent with normal intraday patterns.1d ago
7
GNRCGenerac Holdings Inc.
$205.45▲ 9.87%30D: +3.73%
High: $205.45Low: $187.00Risk: High
55 changes
Material / EarningsGenerac Holdings Inc. (GNRC) moved +8.76% from $188.91 to $205.45 on 2026-11-18 after the company's PWRmicro microinverter won Best in Show at the 2026 Solar Power World Top Products Awards. Volume traded was 2.3x the 5-day average, indicating elevated institutional interest.1d ago
8
AAOIApplied Optoelectronics, Inc.
$40.79▼ 9.80%30D: -52.69%
High: $86.22Low: $40.79Risk: High
87 changes
RiskApplied Optoelectronics filed a material event 8-K today, triggering a sharp intraday decline of 13.23% from $45.22 to $39.24 (per FMP delayed data). Volume surged to 10.6M shares, 4.26x the typical level at this point in the session, signaling urgent investor reaction to the undisclosed material event.1d ago
9
CBRSCerebras Systems Inc.
$94.15▼ 9.63%30D: -33.45%
High: $141.48Low: $94.15Risk: High
85 changes
ValuationCerebras Systems surged 8.24% to $105.80 following a strong Q3 2026 earnings beat, raised full-year revenue guidance, and announcement of a new cloud infrastructure deal with Microsoft, per Reuters and Invezz. The AI chipmaker reported record Q3 GAAP revenue of $210.8M and posted its first quarterly adjusted profit as a public company, projecting annual revenue will triple in 2027.6d ago
10
RBRKRubrik, Inc.
$110.00▲ 9.26%30D: -3.42%
High: $113.90Low: $100.68Risk: High
59 changes
ActivityRubrik announced protection capabilities for Microsoft Azure Cosmos DB, expanding its data management platform into a key cloud database service (Business Wire). The stock rose 7.08% to $107.81 intraday. Volume of 299,125 shares ran 0.68x the time-adjusted historical average, suggesting modest participation in the move.1d ago
11
FROGJFrog Ltd.
$114.38▲ 8.83%30D: +24.38%
High: $114.38Low: $91.96Risk: Low
55 changes
No changes detected this week
12
AKAMAkamai Technologies, Inc.
$91.70▲ 8.34%30D: -0.01%
High: $91.71Low: $84.64Risk: High
72 changes
ActivityAkamai announced an expansion of its enterprise security controls to Microsoft Edge for Business Browser on mobile, according to Globe Newswire. The stock rose 6.36% to $90.02 from $84.64, trading on normal volume (0.97x average) early in the session.1d ago
13
TJXThe TJX Companies, Inc.
$140.30▲ 8.05%30D: -1.77%
High: $142.83Low: $129.85Risk: High
59 changes
ActivityTJX beat Q3 earnings expectations with EPS of $1.34 vs. consensus $1.33 and raised full-year guidance, citing accelerating sales trends through the holiday season (Zacks, WSJ). The stock surged 9.50% from $129.85 to $142.18 on the news.1d ago
14
CRWDCrowdStrike Holdings, Inc.
$237.03▲ 7.95%30D: -4.92%
High: $249.29Low: $219.58Risk: High
85 changes
ValuationCrowdStrike rallied +5.12% to $230.83, driven by a broader AI sector rebound following Nvidia's earnings beat on Tuesday and bullish analyst upgrades ahead of CRWD's own quarterly report (Investing.com). Volume ran 1.84x expected at this point in the session, consistent with normal intraday patterns.1d ago
15
ELVElevance Health Inc.
$400.84▼ 7.63%30D: -6.37%
High: $433.93Low: $400.84Risk: Medium
44 changes
ValuationElevance Health fell 5.26% to $411.09, driven by sector-wide managed-care and Medicaid margin concerns alongside medical cost trend anxiety (elevated ACA and Medicaid claim utilization), per web research. Volume of 551,891 shares in the first 120 minutes represents 1.29x the historical average for this time of day, indicating normal participation for the intraday period.1d ago
16
ASTSAST SpaceMobile, Inc.
$25.49▼ 7.61%30D: -39.51%
High: $42.14Low: $25.49Risk: High
95 changes
ValuationAST SpaceMobile fell 7.64% to $30.11, driven by a combination of broader space-sector weakness—with peers Rocket Lab and Firefly also declining—and pre-conference caution ahead of an investor conference starting November 17 where the market expects concrete updates on commercial service timelines and the Rakuten venture (Benzinga). Volume reached 5.58M shares, 1.29x the intraday average, signaling elevated trading activity.3d ago
17
OSCROscar Health, Inc.
$27.57▼ 7.61%30D: -19.67%
High: $34.32Low: $27.57Risk: High
56 changes
No changes detected this week
18
RBLXRoblox Corporation
$47.33▲ 7.57%30D: -0.44%
High: $47.54Low: $44.00Risk: Medium
66 changes
ValuationRoblox rose 8.27% to $47.64 intraday, though the specific catalyst was not disclosed in available evidence. Finance.yahoo.com articles were cited as sources for today's movement, but their precise content—whether earnings-related, product news, or other developments—could not be verified from the provided data. Volume of 3.6M shares ran at 0.81x the historical average, consistent with normal mid-session trading.1d ago
19
SSRMSSR Mining Inc.
$24.19▼ 7.42%30D: -21.21%
High: $30.70Low: $24.19Risk: High
42 changes
No changes detected this week
20
SGISomnigroup International Inc
$62.45▲ 7.39%30D: +0.66%
High: $62.45Low: $58.15Risk: High
45 changes
No changes detected this week
21
DINOHF Sinclair Corporation
$90.64▼ 7.24%30D: -29.02%
High: $127.69Low: $90.64Risk: Medium
57 changes
No changes detected this week
22
CDECoeur Mining, Inc.
$12.24▼ 7.06%30D: -18.29%
High: $14.98Low: $12.24Risk: Low
47 changes
ValuationCoeur Mining fell 6.34% to $13.09 as precious metals sector weakness pressured the stock. Spot silver prices dropped sharply toward $46.80–$47.00/oz and gold futures hit multi-month lows, driven by a stronger U.S. dollar and rising expectations for a December Fed rate hike (Fortune). The decline also reflects lingering caution from the company's Q3 earnings report released earlier in November and recent analyst target adjustments. Volume of 36.3M shares was normal for the session timing.3d ago
23
CNCCentene Corp.
$67.45▼ 7.03%30D: -3.86%
High: $72.55Low: $67.45Risk: High
46 changes
RiskCentene shares fell 6.78% to $67.63 as managed-care and HMO stocks experienced sector-wide profit-taking and consolidation. The decline follows a sharp multi-week rally post-Q3 earnings and raised 2026 guidance, with investors locking in gains amid reassessment of valuations and underlying Medicaid policy headwinds including eligibility changes and cost pressures on government-sponsored plans. Volume was 0.60x expected at this time of day, suggesting measured selling rather than panic.1d ago
24
IBRXImmunityBio, Inc.
$6.70▲ 7.03%30D: -32.39%
High: $9.91Low: $6.26Risk: High
61 changes
RiskImmunityBio announced findings from a national survey of military service members and veterans with non-muscle invasive bladder cancer, showing 53% were diagnosed at age 50 or younger and revealing barriers to care (Business Wire, 2026-11-11). The stock fell 6.17% to $6.26 on above-average volume (1.78x normal), though the survey is epidemiological rather than clinical trial data.7d ago
25
RIOTRiot Platforms, Inc.
$18.24▲ 6.98%30D: +20.79%
High: $18.24Low: $15.10Risk: High
77 changes
No changes detected this week
26
FCXFreeport-McMoRan Inc.
$51.45▼ 6.96%30D: -26.10%
High: $69.62Low: $51.45Risk: High
60 changes
ValuationFreeport-McMoRan fell 5.75% to $52.12, driven by a combination of subsidiary debt news and analyst downgrade. PT Freeport Indonesia (FCX's 48.76%-owned subsidiary) priced $750 million of senior notes due 2033 at 6.90%, raising debt refinancing concerns, while Erste Group Bank downgraded FCX from buy to hold on November 18, 2026. The decline reflects broader pressure on copper miners amid commodity price volatility.1d ago
27
ZSZscaler, Inc.
$197.83▲ 6.83%30D: -10.40%
High: $220.79Low: $185.19Risk: High
80 changes
No changes detected this week
28
HLHecla Mining Company
$11.67▼ 6.64%30D: -21.68%
High: $14.90Low: $11.67Risk: High
46 changes
RiskHecla Mining declined 5.87% to $12.33 as precious metals sold off broadly on hawkish Federal Reserve signals and elevated Treasury yields following hot inflation data, according to web sources. Silver and gold miners tracked downward pressure on spot prices, with the stronger U.S. dollar reducing overseas demand for dollar-denominated commodities. Volume reached 19.7M shares (1.17x normal for this time of session), consistent with sector-wide selling.3d ago
29
MOHMolina Healthcare, Inc.
$206.56▼ 6.62%30D: -1.26%
High: $221.21Low: $206.56Risk: High
38 changes
No changes detected this week
30
DVADaVita Inc.
$161.79▼ 6.48%30D: -10.46%
High: $180.70Low: $161.79Risk: High
53 changes
No changes detected this week
Change Categories
Types of changes detected this week
Material / Earnings19
Activity12
Risk29

Side-by-Side Comparison

30-day snapshot across all tracked stocks

Symbol
Price
1D %
30D %
30D High
30D Low
Risk
Changes
PSKY
$9.77
▲ 41.39%
▲ 38.39%
$9.77
$6.91
High
45
HUM
$385.78
▼ 12.98%
▼ 9.74%
$443.34
$385.78
Low
65
OKTA
$195.61
▲ 12.07%
▼ 7.70%
$211.92
$174.54
High
67
SAIL
$22.25
▲ 10.26%
▲ 15.28%
$22.25
$19.30
Medium
51
UNH
$349.91
▼ 10.21%
▼ 11.55%
$395.62
$349.91
High
74
PANW
$339.92
▲ 9.90%
▼ 9.36%
$375.04
$309.29
High
82
GNRC
$205.45
▲ 9.87%
▲ 3.73%
$205.45
$187.00
High
55
AAOI
$40.79
▼ 9.80%
▼ 52.69%
$86.22
$40.79
High
87
CBRS
$94.15
▼ 9.63%
▼ 33.45%
$141.48
$94.15
High
85
RBRK
$110.00
▲ 9.26%
▼ 3.42%
$113.90
$100.68
High
59
FROG
$114.38
▲ 8.83%
▲ 24.38%
$114.38
$91.96
Low
55
AKAM
$91.70
▲ 8.34%
▼ 0.01%
$91.71
$84.64
High
72
TJX
$140.30
▲ 8.05%
▼ 1.77%
$142.83
$129.85
High
59
CRWD
$237.03
▲ 7.95%
▼ 4.92%
$249.29
$219.58
High
85
ELV
$400.84
▼ 7.63%
▼ 6.37%
$433.93
$400.84
Medium
44
ASTS
$25.49
▼ 7.61%
▼ 39.51%
$42.14
$25.49
High
95
OSCR
$27.57
▼ 7.61%
▼ 19.67%
$34.32
$27.57
High
56
RBLX
$47.33
▲ 7.57%
▼ 0.44%
$47.54
$44.00
Medium
66
SSRM
$24.19
▼ 7.42%
▼ 21.21%
$30.70
$24.19
High
42
SGI
$62.45
▲ 7.39%
▲ 0.66%
$62.45
$58.15
High
45
DINO
$90.64
▼ 7.24%
▼ 29.02%
$127.69
$90.64
Medium
57
CDE
$12.24
▼ 7.06%
▼ 18.29%
$14.98
$12.24
Low
47
CNC
$67.45
▼ 7.03%
▼ 3.86%
$72.55
$67.45
High
46
IBRX
$6.70
▲ 7.03%
▼ 32.39%
$9.91
$6.26
High
61
RIOT
$18.24
▲ 6.98%
▲ 20.79%
$18.24
$15.10
High
77
FCX
$51.45
▼ 6.96%
▼ 26.10%
$69.62
$51.45
High
60
ZS
$197.83
▲ 6.83%
▼ 10.40%
$220.79
$185.19
High
80
HL
$11.67
▼ 6.64%
▼ 21.68%
$14.90
$11.67
High
46
MOH
$206.56
▼ 6.62%
▼ 1.26%
$221.21
$206.56
High
38
DVA
$161.79
▼ 6.48%
▼ 10.46%
$180.70
$161.79
High
53
SRRK
$48.00
▲ 6.48%
▲ 21.21%
$48.00
$39.60
High
45
RGEN
$172.67
▲ 6.47%
▼ 3.10%
$178.20
$162.18
High
48
PS
$40.60
▼ 6.41%
▼ 10.93%
$45.58
$40.60
High
62
MSTR
$90.32
▼ 6.40%
▼ 36.94%
$143.24
$90.32
High
92
M
$24.88
▲ 6.37%
▲ 9.70%
$24.88
$22.68
High
52
MOD
$137.88
▲ 6.28%
▼ 12.60%
$157.75
$129.73
High
84
CVLT
$150.95
▲ 6.27%
▼ 2.19%
$154.33
$142.04
Medium
65
TTWO
$216.61
▲ 6.22%
▲ 7.64%
$216.61
$201.23
High
63
NEM
$104.53
▼ 6.05%
▼ 6.30%
$111.56
$104.53
High
58
HUT
$57.19
▲ 5.97%
▼ 23.61%
$74.87
$53.97
High
69
SCCO
$146.21
▼ 5.93%
▼ 26.37%
$198.58
$146.21
High
44
FTNT
$131.81
▲ 5.87%
▼ 28.38%
$184.05
$124.50
High
74
MDGL
$398.08
▼ 5.67%
▼ 13.46%
$460.01
$398.08
High
53
NET
$300.91
▲ 5.66%
▼ 7.22%
$324.33
$284.80
High
84
KRYS
$315.34
▲ 5.62%
▼ 4.64%
$330.69
$298.55
High
38
VLO
$343.70
▼ 5.52%
▼ 25.25%
$459.78
$343.70
High
79
MPC
$373.86
▼ 5.50%
▼ 22.90%
$484.92
$373.86
High
64
IONQ
$23.48
▼ 5.48%
▼ 25.27%
$31.42
$23.48
High
97
BURL
$247.97
▲ 5.46%
▼ 5.81%
$263.26
$235.14
High
42
TGTX
$66.12
▲ 5.44%
▲ 21.61%
$66.12
$54.37
Medium
49

Recent Change Activity

All changes in the past 7 days

Material / Earnings
OKTA
Okta, Inc. (OKTA) moved +9.90% from $177.99 to $195.61 on 2026-11-18. We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was found. The move occurred on elevated volume (2.3x the 5-day average), suggesting institutional interest, though the trigger remains unclear.
1d ago
Material / Earnings
GNRC
Generac Holdings Inc. (GNRC) moved +8.76% from $188.91 to $205.45 on 2026-11-18 after the company's PWRmicro microinverter won Best in Show at the 2026 Solar Power World Top Products Awards. Volume traded was 2.3x the 5-day average, indicating elevated institutional interest.
1d ago
Material / Earnings
SNEX
StoneX Group Inc. (SNEX) reported EPS of $0.66 vs. consensus estimate of $0.88, missing by 25.0% on 2026-11-18.
1d ago
Valuation
CVS
CVS Health fell 5.16% to $81.38, driven by a confluence of headwinds: a new CMS Medicare Advantage and Part D oversight rule proposed November 16 (per web catalyst), ongoing investor concerns about execution risks tied to CVS's November 4 breakup plan to separate retail pharmacy from Aetna and Caremark, and multiple analyst price-target cuts from RBC Capital, Wells Fargo, Raymond James, and Bank of America. Volume at 11.4M shares ran 1.1x normal for this time of session.
1d ago
Risk
CNC
Centene shares fell 6.78% to $67.63 as managed-care and HMO stocks experienced sector-wide profit-taking and consolidation. The decline follows a sharp multi-week rally post-Q3 earnings and raised 2026 guidance, with investors locking in gains amid reassessment of valuations and underlying Medicaid policy headwinds including eligibility changes and cost pressures on government-sponsored plans. Volume was 0.60x expected at this time of day, suggesting measured selling rather than panic.
1d ago
Risk
VLO
Valero Energy shares fell 5.28% to $344.56, driven by a sharp pullback in crude oil prices and rising U.S. crude and gasoline inventories. WTI crude dropped over 3% to near $81.50 a barrel today, while API data showed a large build-up in both crude and fuel stocks, pressuring refiner crack spreads (per web catalyst synthesis). The decline follows a multi-month rally in VLO, suggesting profit-taking as energy markets rebalance.
1d ago
Valuation
RBLX
Roblox rose 8.27% to $47.64 intraday, though the specific catalyst was not disclosed in available evidence. Finance.yahoo.com articles were cited as sources for today's movement, but their precise content—whether earnings-related, product news, or other developments—could not be verified from the provided data. Volume of 3.6M shares ran at 0.81x the historical average, consistent with normal mid-session trading.
1d ago
Activity
NET
CFO Thomas Seifert delivered an upbeat business update at the RBC Global Technology, Internet, Media and Telecommunications Conference, highlighting simultaneous improvements across revenue, customer growth, retention, margins, and pipeline, while emphasizing Cloudflare's positioning around the 'agentic cloud' to support AI traffic (web_catalyst). NET rose 6.83% to $304.26, building on momentum from Q3 2026 earnings (reported Nov 5) that showed 39.2% YoY revenue growth to $782.51M and raised FY2026 guidance to ~$2.96B. Volume at 1,646,959 shares is tracking at 0.85x expected for 180 minutes into the session.
1d ago
Activity
FTNT
Fortinet shares rose 6.17% to $132.19, rebounding from an oversold level following a steep post-earnings sell-off in late October. Per the web catalyst, investors are re-evaluating the company's raised full-year 2026 guidance, strong product demand, and expanding AI security offerings after initially focusing on slower service-revenue growth and margin pressure. Volume of 1.68M shares was 0.60x the time-adjusted average, indicating below-average participation in the rally.
1d ago
Activity
AKAM
Akamai announced an expansion of its enterprise security controls to Microsoft Edge for Business Browser on mobile, according to Globe Newswire. The stock rose 6.36% to $90.02 from $84.64, trading on normal volume (0.97x average) early in the session.
1d ago
Valuation
ELV
Elevance Health fell 5.26% to $411.09, driven by sector-wide managed-care and Medicaid margin concerns alongside medical cost trend anxiety (elevated ACA and Medicaid claim utilization), per web research. Volume of 551,891 shares in the first 120 minutes represents 1.29x the historical average for this time of day, indicating normal participation for the intraday period.
1d ago
Valuation
HUM
Humana shares fell 12.03% to $390.00 on regulatory and audit scrutiny targeting Medicare Advantage programs. The Centers for Medicare & Medicaid Services (CMS) announced plans to codify removal of a fee-for-service adjuster and extrapolate audit findings effective payment year 2018, with the rule due for Federal Register publication November 19, per web reports. A proposed federal fraud and waste rule also raised concerns over stricter reporting requirements and potential financial liability for Medicare Advantage insurers. The selloff is sector-wide: UnitedHealth Group, Elevance Health, Centene, and Molina Healthcare also declined, though Humana's 12% move is steeper. Volume reached 2.74M shares (2.06x time-adjusted average), reflecting elevated institutional repositioning.
1d ago
Risk
NEM
Gold prices plunged over 2% to near $3,757–$3,765 per ounce (a 14-month low), driven by hawkish Federal Reserve pricing and a surging U.S. dollar index hitting multi-month highs. As a premier gold producer with high operating leverage to bullion prices, Newmont fell 6.86% to $103.63 (from $111.26), with volume at 1.75x expected levels for this time of day. Near-term cost pressures—with management projecting all-in sustaining costs near $1,900 per ounce for Q4—compound margin concerns amid the commodity headwind.
1d ago
Risk
CRWV
CoreWeave shares fell 6.13% to $46.83, reversing earlier momentum tied to Nvidia's earnings boost. Despite company claims of 10x demand versus available supply (Motley Fool), Seeking Alpha highlighted credit risk concerns as potentially mispriced, weighing on sentiment intraday. Volume of 26.2M shares ran 2.0x normal levels for this time of day.
1d ago
Activity
MP
MP Materials shares rose 7.17% to $37.36 on institutional buying activity. Commonwealth Equity Services LLC purchased shares in MP, per defenseworld.net. Trading volume reached 3.03M shares—nearly 3x the time-adjusted average—signaling elevated institutional interest in the rare-earth materials producer.
1d ago
Valuation
CBRS
Cerebras Systems fell 7.71% to $96.15 following a cascade of analyst price-target cuts post-earnings, combined with an active shareholder investigation and insider selling pressure. UBS cut its target to $155 from $250, Needham to $200 from $300, and Mizuho to $240 from $300 (per web catalyst synthesis). Volume reached 6.39M shares, 1.33x the time-adjusted average, reflecting elevated trading activity amid sector-wide AI infrastructure caution.
1d ago
Risk
SCCO
Southern Copper fell 7.14% to $144.33 as global copper prices crashed to multi-month lows amid an unwinding of AI-driven infrastructure demand expectations and a stronger U.S. dollar, per Morningstar and Bloomberg reporting on November 18. COMEX and LME copper futures dropped 3–4% below $5.75/lb, driven by speculative selling and cautious commentary from prominent macro investors on long-term data center demand. Volume was elevated at 3.31x the time-adjusted average, reflecting broad sector de-risking in base metals.
1d ago
Valuation
DIS
Disney shares rallied 4.92% to $122.69 following yesterday's fiscal Q4 earnings beat and a new $3 billion cost-saving plan, with at least seven Wall Street analysts raising price targets in response (Benzinga). JPMorgan and Wells Fargo both lifted targets to $140, citing consistent earnings growth and improving margins. Volume was 1.41x expected at this point in the session, indicating normal intraday participation.
1d ago
Valuation
CRWD
CrowdStrike rallied +5.12% to $230.83, driven by a broader AI sector rebound following Nvidia's earnings beat on Tuesday and bullish analyst upgrades ahead of CRWD's own quarterly report (Investing.com). Volume ran 1.84x expected at this point in the session, consistent with normal intraday patterns.
1d ago
Risk
IONQ
IonQ fell 5.01% to $23.59, extending a sharp six-month decline (Motley Fool reports a 48% drop since mid-2026), despite positive Q3 results from its SkyWater acquisition that boosted revenues and expanded RPO (Zacks). Volume of 12M shares ran 1.78x the historical average at 120 minutes into the session, indicating elevated selling pressure amid the broader weakness.
1d ago
Activity
RBRK
Rubrik announced protection capabilities for Microsoft Azure Cosmos DB, expanding its data management platform into a key cloud database service (Business Wire). The stock rose 7.08% to $107.81 intraday. Volume of 299,125 shares ran 0.68x the time-adjusted historical average, suggesting modest participation in the move.
1d ago
Valuation
TTWO
Take-Two Interactive shares surged 7.10% to $218.41 on the imminent midnight release and near-perfect critical reviews of Grand Theft Auto VI, with early scores including rare 10/10 ratings from major outlets (Reuters, Benzinga). Volume traded 4.67x the historical average at this time of day, with pre-orders tracking well above initial expectations ahead of the official launch.
1d ago
Valuation
ASTS
AST SpaceMobile fell 7.65% to $25.48 following analyst downgrade and renewed concerns over launch delays. Seeking Alpha published a rating downgrade citing a 'launch bottleneck,' while Motley Fool noted the company has pushed its launch target to 2027 and the stock is trading 78% below its all-time high. Volume of 9.3M shares ran 1.41x the intraday average, indicating elevated selling pressure.
1d ago
Valuation
MSTR
Strategy Inc (MSTR) fell 3.60% to $93.03 as Bitcoin declined and crypto sector pressure mounted. According to 247wallst.com, an analyst warned of a potential 76% downside target to $23, while the Motley Fool highlighted structural differences between crypto-exposed stocks during the selloff. Volume surged to 2.54x the intraday average at 6.91M shares, signaling elevated selling pressure.
1d ago
Valuation
TGT
Target reported fiscal Q3 2026 earnings that beat expectations on both sales and profit, driving the 5.65% intraday rally. Net sales of $27.07 billion exceeded consensus by $520 million, comparable sales rose 5.6% (driven by 5% traffic growth and 9.8% digital growth), and EPS jumped to $2.65 from $1.51 year-ago, aided by a $228 million tariff refund benefit. Management raised full-year net sales growth guidance to ~6% and boosted full-year EPS guidance to $10.65–$11.40. Volume surged to 5.0M shares, 3.39x the typical pace 150 minutes into the session, per The Wall Street Journal and web catalyst reporting.
1d ago
Activity
PANW
Palo Alto Networks rose 8.22% to $334.72 ahead of its Q1 FY2027 earnings report (due after today's close), driven by a combination of heightened cybersecurity threat warnings and broader AI/tech momentum. Homeland Security Secretary Markwayne Mullin warned in congressional testimony of threats from Iranian-backed actors targeting U.S. financial, energy, and transportation systems, alongside AI-driven attack scaling, lifting demand for Palo Alto's Prisma AIRS platform and broader security solutions. Volume at 6.64M shares is 1.41x expected for this point in the session, consistent with normal intraday patterns.
1d ago
Material / Earnings
TGT
Target Corporation (TGT) reported EPS of $2.65 vs. consensus estimate of $2.08, beating estimates by 27.4% on 2026-11-18.
1d ago
Risk
UNH
UnitedHealth Group fell 6.95% to $362.61, declining nearly $27 per share on elevated volume (2.68x expected for this time of day). No major negative catalyst appeared in news flow; a UnitedHealthcare announcement on rural pharmacy access and commentary on 13–16% long-term earnings growth targets were published, but neither explains the sharp intraday drop. The selloff occurs amid broad market conditions and ahead of UNH's January 20 earnings release.
1d ago
Valuation
FCX
Freeport-McMoRan fell 5.75% to $52.12, driven by a combination of subsidiary debt news and analyst downgrade. PT Freeport Indonesia (FCX's 48.76%-owned subsidiary) priced $750 million of senior notes due 2033 at 6.90%, raising debt refinancing concerns, while Erste Group Bank downgraded FCX from buy to hold on November 18, 2026. The decline reflects broader pressure on copper miners amid commodity price volatility.
1d ago
Risk
AAOI
Applied Optoelectronics filed a material event 8-K today, triggering a sharp intraday decline of 13.23% from $45.22 to $39.24 (per FMP delayed data). Volume surged to 10.6M shares, 4.26x the typical level at this point in the session, signaling urgent investor reaction to the undisclosed material event.
1d ago
Valuation
WULF
TeraWulf rose 7.97% to $12.60, driven by a sector-wide rally in AI data center stocks following NVIDIA's record quarterly results and stronger-than-expected $130 billion Q4 revenue forecast. Since TeraWulf generates approximately 83% of revenue from leasing high-performance computing capacity to AI tenants, NVIDIA's strong outlook reinforced demand expectations for TeraWulf's infrastructure, with peers like Cipher Digital (CIFR) and IREN also climbing.
1d ago
Activity
TJX
TJX beat Q3 earnings expectations with EPS of $1.34 vs. consensus $1.33 and raised full-year guidance, citing accelerating sales trends through the holiday season (Zacks, WSJ). The stock surged 9.50% from $129.85 to $142.18 on the news.
1d ago
Material / Earnings
SNAP
Snap Inc. (SNAP) moved +7.32% from $5.12 to $5.50 on November 17, 2026. No new company-specific catalyst was announced on the move date. The rally appears to be a technical relief bounce after SNAP fell roughly 17% over the preceding month, including a 14% post-earnings decline following its November 4 Q3 report where ad growth and North American daily active users missed expectations. Trading volume on the bounce was elevated at 2.0x the 5-day average.
2d ago
Material / Earnings
RYTM
Rhythm Pharmaceuticals, Inc. (RYTM) moved +9.49% from $106.50 to $116.61 on 2026-11-17 after presenting two-year Phase 3 TRANSCEND trial data showing setmelanotide sustained BMI reductions in acquired hypothalamic obesity. Volume was 2.8x the 5-day average.
2d ago
Material / Earnings
NKE
NIKE, Inc. (NKE) moved -10.82% from $40.20 to $35.85 on 2026-11-17, reaching a new 30-day low on volume 3.8x the 5-day average. The sell-off came after Nike announced a $12 billion shareholder dividend distribution and projected $5 billion incremental revenue growth by 2031 as part of its 'Full Stride Ahead' growth strategy, with management emphasizing performance athleticwear as a long-term growth driver.
2d ago
Valuation
AFRM
Affirm Holdings fell 5.07% to $59.53 as a sector-wide repricing of buy-now-pay-later and fintech lenders intensified, driven by rising Treasury yields (10-year near 5.1%) that increase the company's cost of capital and pressure long-duration consumer receivables, combined with fresh analyst price-target cuts from firms like Truist Financial and lingering credit-quality concerns following Affirm's early November earnings report. Broader tech and financial sector weakness added to the selloff.
2d ago
Risk
WDAY
Workday fell 4.14% to $186.02 amid pre-earnings nervousness and a broader software-sector pullback. With earnings due November 24, options markets are pricing in an expected post-earnings move of ~7%, prompting investors to trim exposure ahead of the report. Peer enterprise software names (Salesforce, Intuit, Adobe) are also trading lower as the market reassesses how autonomous AI agents and shifting IT budgets will impact legacy SaaS platform demand.
2d ago
Valuation
INTU
Intuit fell 6.57% to $322.86 as the tech sector weakened following former Nvidia CEO Jensen Huang's resignation (Motley Fool, Nov. 17). The sell-off intensifies pre-earnings caution: INTU reports Q1 fiscal 2027 results on Nov. 19, and the web_catalyst notes lingering pressure from earlier workforce reductions and softness in legacy DIY tax and Mailchimp segments. Volume was 1.13x typical for this stage of the session—normal trade.
2d ago
Activity
ACM
Aecom filed an 8-K material event disclosure and earnings report today, triggering a 9.43% intraday rally to $79.33. Volume surged to 3.29x the time-adjusted average (988,187 shares in 90 minutes), signaling strong institutional interest. The specific content of the 8-K and earnings details are not yet public in available sources, but the dual filing suggests a significant corporate development or beat.
2d ago
Risk
NXT
Nextpower Inc. (NXT) fell 6.70% to $83.33 intraday following a Capital Markets Day event (Business Wire). The decline occurred on volume 1.45x the time-adjusted average, suggesting coordinated selling rather than thin liquidity.
2d ago
Risk
MSTR
Strategy Inc (MSTR) fell 3.65% to $99.27 in early trading with volume at 1.56x normal levels for this session time. No specific intraday catalyst was identified in news or filings; the decline occurred alongside typical trading activity without announcement-driven moves.
2d ago
Valuation
MDB
MongoDB announced an agreement to acquire Firebolt Analytics Inc., a real-time analytics platform, to expand its Intelligent Data Platform — a move that triggered investor concerns about execution and integration risks. The stock fell 5.44% to $299.68 on the news (per FMP delayed intraday), with volume at 1.06x expected levels — normal for this time of session. The SEC 8-K filing and investor relations update confirmed the transaction details today.
2d ago
Risk
CRCL
Circle Internet Group (CRCL) fell 3.10% to $55.86 as of midday trading. Commonwealth Equity Services LLC acquired 11,808 shares, per defenseworld.net; volume stands at 2.14M shares (1.42x the time-adjusted expected level), indicating normal intraday activity.
2d ago
Valuation
IONQ
IonQ fell 5.14% to $25.09 following a Seeking Alpha downgrade citing shareholder dilution concerns amid quantum progress. Volume surged to 7.3M shares, running 2.18x the typical pace for this time of day, signaling coordinated selling pressure.
2d ago
Risk
NOW
ServiceNow announced a surge in AI usage and raised its annual contract value target to $1.7 billion (per MarketBeat), yet shares fell 5.64% to $93.77. The disconnect suggests investors may be digesting the guidance raise against current valuation or profit-taking after a likely recent run-up; volume at 1.60x the time-adjusted average indicates moderate institutional participation in the sell-off.
2d ago
Risk
NKE
Nike shares fell 7.48% to $35.40 intraday despite positive forward guidance. The Wall Street Journal and Reuters reported Nike expects performance athleticwear to drive long-term growth and $5 billion in incremental revenue by 2031, while the company plans $12 billion in shareholder distributions via dividends. Volume surged to 51.5M shares (2.61x typical for this time of day), suggesting heavy selling pressure that overwhelmed the constructive guidance narrative.
2d ago
Risk
SMMT
Summit Therapeutics filed a material event (8-K) today, triggering a 9.21% intraday decline to $10.73. The specific details of the filing were not disclosed in available sources, but the timing coincides with elevated volume at 2.11x the session average, suggesting market reaction to a material announcement from the company.
2d ago
Valuation
CRM
Salesforce fell 9.46% to $194.50, driven by a confluence of AI monetization skepticism, sector-wide SaaS rotation, and balance-sheet concerns tied to recent M&A including the $5.7 billion Braze acquisition (per web sources). Volume surged to 2.24x the expected level 150 minutes into the session, signaling institutional selling pressure as the stock broke through key technical support.
2d ago
Material / Earnings
POWL
Powell Industries, Inc. (POWL) reported EPS of $2.23 vs. consensus estimate of $1.57, beating by 42.0% on 2026-11-16.
3d ago
Valuation
CDE
Coeur Mining fell 6.34% to $13.09 as precious metals sector weakness pressured the stock. Spot silver prices dropped sharply toward $46.80–$47.00/oz and gold futures hit multi-month lows, driven by a stronger U.S. dollar and rising expectations for a December Fed rate hike (Fortune). The decline also reflects lingering caution from the company's Q3 earnings report released earlier in November and recent analyst target adjustments. Volume of 36.3M shares was normal for the session timing.
3d ago
Risk
FCX
Freeport-McMoRan fell 6.93% to $55.13 after subsidiary PT Freeport Indonesia announced a U.S. dollar-denominated senior notes offering to refinance existing debt, per web sources citing the filing. The decline also reflects investor concern over the company's $4.5 billion Bagdad mine expansion project and broader commodity sector weakness, with volume at 1.13x normal for the time of session.
3d ago
Risk
KTOS
Kratos Defense fell 6.30% to $31.77 intraday despite positive momentum in defense spending and the company's expansion into hypersonic technologies and advanced manufacturing, as reported by Zacks on November 16. Volume traded 0.61x expected levels at this point in the session, suggesting below-average participation in the selloff.
3d ago
Risk
CORT
Corcept Therapeutics fell 5.38% to $69.02, driven by a combination of post-earnings valuation cooldown following strong Q3 2026 results reported November 3, and competitive pressures in oncology from rival trial data (including Genmab's Phase 3 ovarian cancer therapy results in late October) that raised questions about the commercial trajectory of Corcept's newly launched Lifyorli® (relacorilant). Volume traded 496,998 shares by the 320-minute mark, approximately 0.47x the expected daily average for that time—below typical levels.
3d ago
Valuation
TWST
Twist Bioscience shares fell 5.22% to $105.78 following investor disappointment with the company's fiscal 2027 outlook, despite better-than-expected quarterly results. Multiple covering analysts subsequently lowered their price targets on the stock, adding downward pressure to the decline.
3d ago
Valuation
RGTI
Rigetti Computing shares fell 5.04% to $9.13, driven by a combination of disappointing third-quarter results and multiple analyst price-target cuts. The company reported Q3 revenue of $1.41 million versus $3.67 million expected, along with widening operating losses ($110 million) and negative free cash flow ($111 million) over 12 months; Mizuho, Needham, and Jefferies subsequently cut price targets to $17, $15, and $12 respectively (per Motley Fool). Volume of 10.3 million shares was 0.84x the time-adjusted expected level—normal for intraday.
3d ago
Risk
HIMS
Hims & Hers Health declined 4.18% to $18.91 following recent earnings that revealed a net loss despite 49% revenue growth, driven by deteriorating gross margins according to the Motley Fool (November 16). Volume of 6.8 million shares was below average for this point in the session, suggesting modest participation in the sell-off.
3d ago
Activity
POWL
Powell Industries shares rose 6.57% to $152.10 ahead of fiscal Q4 2026 earnings scheduled for release after market close today (November 16), according to Google Finance and Yahoo Finance coverage. Elevated volume of 2.62x the time-adjusted average signals active positioning by investors anticipating the results, which carry a consensus EPS estimate of $1.52 (up 7.8% year-over-year) and expected quarterly revenue around $328.35 million.
3d ago
Risk
HL
Hecla Mining declined 5.87% to $12.33 as precious metals sold off broadly on hawkish Federal Reserve signals and elevated Treasury yields following hot inflation data, according to web sources. Silver and gold miners tracked downward pressure on spot prices, with the stronger U.S. dollar reducing overseas demand for dollar-denominated commodities. Volume reached 19.7M shares (1.17x normal for this time of session), consistent with sector-wide selling.
3d ago
Valuation
ARWR
Arrowhead Pharmaceuticals extended a post-earnings sell-off that began following the company's November 12 quarterly results, which reported a loss of -$5.11 per share, well below expectations. The stock declined 4.76% to $45.50 on November 16, with volume at 0.56x the time-adjusted average, indicating below-average trading activity during the decline. The sell-off persists despite the company's November 4 announcement of a $400 million senior secured term loan refinancing with Sixth Street to lower borrowing costs.
3d ago
Risk
HOOD
Robinhood fell 7.57% to $71.97 as a crypto market selloff, regulatory headwinds, and insider selling pressured the stock. Bitcoin dropped sharply toward $64,000—its weakest level since July—triggering multi-billion-dollar ETF outflows that dampened retail trading activity on the platform. Louisiana's Attorney General filed a lawsuit targeting Robinhood's prediction markets business, a key growth segment. A Form 144 insider sale notice on November 15 compounded the selling pressure amid a broader risk-off market tone (Benzinga, defenseworld.net).
3d ago
Risk
CYTK
Cytokinetics announced expanded prescribing information for MYQORZO® (aficamten) incorporating Phase 3 MAPLE-HCM trial data, positioning the drug for a new heart-disease indication (Globe Newswire, 2026-11-16). Despite the clinical milestone, CYTK declined 4.40% to $53.66 intraday from $56.13. Trading volume stands at 0.50x the time-adjusted average, suggesting light participation.
3d ago
Valuation
ALB
Albemarle fell 4.12% to $89.68, hitting a new 52-week low, driven by a combination of soft lithium market pricing and recent analyst price-target cuts from major firms including Morgan Stanley, Bank of America, Deutsche Bank, and UBS. The decline reflects caution over near-term demand visibility and sequential deceleration expected in Q4 due to higher-cost inventory drawdown, despite ALB's Q3 earnings beat in early November.
3d ago
Valuation
ASTS
AST SpaceMobile fell 7.64% to $30.11, driven by a combination of broader space-sector weakness—with peers Rocket Lab and Firefly also declining—and pre-conference caution ahead of an investor conference starting November 17 where the market expects concrete updates on commercial service timelines and the Rakuten venture (Benzinga). Volume reached 5.58M shares, 1.29x the intraday average, signaling elevated trading activity.
3d ago
Valuation
GAP
Gap Inc. declined 5.53% to $19.91 as investors positioned defensively ahead of Q3 earnings scheduled for November 19, 2026 (after market close Thursday). The pullback reflects caution around holiday demand, Athleta's performance, and Old Navy's recovery trajectory, compounded by a recent Wells Fargo price target cut. Volume at 1.17x normal levels suggests orderly, anticipatory selling rather than panic.
3d ago
Valuation
CGON
CG Oncology announced positive Phase 3 PIVOT-006 trial results for cretostimogene in intermediate-risk and high-grade Ta non-muscle-invasive bladder cancer, with the company stating it is the first therapeutic to demonstrate significant recurrence benefit in this patient population (web catalyst). Stock surged +14.35% to $85.08 on 7.22x elevated volume, with the data triggering plans for two BLA filings in 2027.
3d ago
Valuation
SMCI
SMCI fell 4.91% to $25.55 on November 16, 2026, driven primarily by ongoing fallout from a reported Department of Justice smuggling investigation into whether entities tied to a former Megaspeed International executive helped smuggle Super Micro servers into China, compounded by sector-wide pressure on AI hardware makers. The stock has now declined 16.46% since November 2. Volume of 15.6 million shares was 0.85x the adjusted historical average at 150 minutes into the session.
3d ago
Valuation
SMMT
Summit Therapeutics received a Complete Response Letter (CRL) from the FDA for ivonescimab, its lead lung cancer drug, due to the absence of a statistically significant overall survival benefit in the HARMONi study—blocking the company's path to approval in its current form (Barron's, Benzinga). The stock plunged 15.34% to $11.98, with volume at 5.55x the expected level for this time of trading session, reflecting the market's immediate reaction to the regulatory setback for SMMT's flagship asset.
3d ago
Risk
COIN
Bitcoin selloff deepening, combined with institutional investor rebalancing. Per 247wallst.com, a broad crypto strategy declined 8% as Bitcoin weakness accelerated, pulling Coinbase down 7% alongside Microstrategy (MARA). Additionally, defenseworld.net reported that Eurizon Capital SGR reduced its COIN holdings. Stock fell 7.92% from $127.65 to $117.54 intraday.
3d ago
Risk
MSTR
Strategy Inc (MSTR) fell 8.67% to $101.94 as Bitcoin declined to $64,000 and the company faces a potential exit from the MSCI index, according to Benzinga. The stock has tracked Bitcoin volatility closely given Strategy's large digital-asset holdings.
3d ago
Valuation
NTRA
Natera shares fell 6.83% to $297.29 following a stock sale by Eurizon Capital SGR S.p.A., as reported by defenseworld.net. The decline occurred on volume of 591,699 shares (1.10x normal for this time of session), suggesting investor repositioning rather than broad selling pressure.
3d ago
Activity
TSN
Tyson Foods released fourth-quarter and fiscal 2026 financial results (Globe Newswire), missing earnings estimates per Zacks while guiding for a sales decline as the beef business remains under pressure (WSJ). Despite the miss and negative guidance, TSN surged +8.48% from $58.82 to $63.81 intraday—a counterintuitive rally that suggests market sentiment may be pivoting to relative relief or a valuation reset after prior weakness.
3d ago
Material / Earnings
FRMI
Fermi Inc. (FRMI) moved +25.18% from $2.08 to $2.61 on 2026-11-13 after announcing a 600 megawatt power capacity deal with an unnamed investment-grade hyperscaler for its Project Matador site in Texas, which includes a $200 million prepayment and $15 million early construction agreement, with first power delivery targeted for 2027. The company also terminated its TensorWave data-center lease in connection with the new partnership.
6d ago
Valuation
SMMT
Summit Therapeutics fell 6.03% to $14.17 on pre-catalyst de-risking ahead of an imminent FDA decision on ivonescimab for lung cancer, scheduled for November 14, 2026 (per web search and Yahoo Finance). Institutional investors are reducing exposure before the binary regulatory event despite the drug showing progression-free survival benefits in trials; uncertainty around overall survival data and Western-specific requirements is tempering confidence.
6d ago
Risk
RGTI
Rigetti dropped 7.07% to $9.60 as quantum computing stocks broadly sold off following sector headwinds. IonQ fell 8% and D-Wave declined 4–5% on the same day (247wallst.com, 2026-11-13), with the group pressured by a recent CEO admission that quantum computing cannot yet demonstrate clear return on investment and widening Q3 losses at Rigetti despite revenue growth. Volume is running 1.09x normal for this time of session.
6d ago
Valuation
FRMI
Fermi Inc. shares surged 30.10% to $2.68 following announcement of a major hyperscaler deal for 600 megawatts of capacity at its Project Matador site in Texas, secured by a $200 million prepayment and $15 million early construction agreement, according to the web catalyst. The rally extends momentum from the prior session despite today's earnings report showing a wider-than-expected Q3 net loss of $141.6 million; volume of 57.1 million shares is running 1.99x the historical average for this point in the session.
6d ago
Valuation
MOD
Modine Manufacturing surged 28.41% to $136.25 following Bloomberg reports that Samsung Electronics is in discussions to acquire the data center cooling specialist in a deal valued around $5.6 billion. Samsung is seeking Modine as a strategic asset to strengthen its AI infrastructure footprint, where liquid and thermal cooling for high-density processors is a critical bottleneck. Volume spiked to 4.88M shares, 7.25x the time-adjusted average, reflecting elevated investor interest.
6d ago
Valuation
CBRS
Cerebras Systems surged 8.24% to $105.80 following a strong Q3 2026 earnings beat, raised full-year revenue guidance, and announcement of a new cloud infrastructure deal with Microsoft, per Reuters and Invezz. The AI chipmaker reported record Q3 GAAP revenue of $210.8M and posted its first quarterly adjusted profit as a public company, projecting annual revenue will triple in 2027.
6d ago
Material / Earnings
TWST
Twist Bioscience Corporation (TWST) moved +14.69% from $99.59 to $114.22 on 2026-11-12 after reporting Q4 FY2026 results. The company reported a loss of $0.32 per share, beating the consensus estimate of $0.39 by 17.33%, alongside Q4 revenue of $126.6 million (beating expectations of $123–124 million) and adjusted EBITDA turning positive at $2.2 million. Full-year revenue grew 22%, with Q4 revenue up 28% year-over-year.
7d ago
Material / Earnings
LGN
Legence Corp. Class A Common stock (LGN) reported EPS of $1.15 vs. consensus estimate of $0.57, beating consensus by 100.7% on 2026-11-12.
7d ago
Material / Earnings
ARWR
Arrowhead Pharmaceuticals, Inc. (ARWR) reported EPS of −$3.04 vs. consensus estimate of −$1.52, missing by 100.0% on 2026-11-12.
7d ago
Material / Earnings
GPN
Global Payments Inc. (GPN) moved -11.95% from $100.16 to $88.19 on 2026-11-12, with volume 2.9x the 5-day average. On the same day, GPN announced integration of Visa's IDX API into its AI authentication platform to reduce false declines and boost payment approvals.
7d ago
Material / Earnings
NVDA
NVIDIA Corporation (NVDA) moved +10.05% from $151.01 to $166.19 on 2026-11-12, rebounding from a sharp decline triggered by CEO Jensen Huang's resignation. Huang stepped down amid governance concerns and personal conduct allegations, with CFO Colette Kress assuming interim leadership. The rebound came as analyst downgrades (Cantor Fitzgerald cut price targets from $350 to $250) and broader market anxiety appeared to stabilize, though volume remained elevated at 2.1x the 5-day average.
7d ago
Material / Earnings
CRWV
CoreWeave, Inc. Class A Common Stock (CRWV) moved +11.21% on 2026-11-12, two days after reporting Q3 results on 2026-11-10. The company reported Q3 revenues surged 168% year-over-year and disclosed a $132.5B backlog, though it also noted a Texas data center moratorium delaying revenue on existing contracts. CRWV met its EPS estimate at –$1.27 vs. –$1.27 consensus (no surprise).
7d ago
Material / Earnings
DELL
Dell Technologies Inc. (DELL) moved +10.44% from $336.09 to $371.17 on 2026-11-12, following CoreWeave's better-than-expected Q3 results and raised guidance, which signaled increased AI spending demand. The move also reflected relief after Dell announced record AI orders and a massive backlog despite earlier sector headwinds.
7d ago
Material / Earnings
CBRS
Cerebras Systems Inc. (CBRS) reported EPS of −$0.67 vs. −$0.15 consensus estimate for Q3 FY2026, missing by 333.5% on November 12, 2026.
7d ago
Risk
IBRX
ImmunityBio announced findings from a national survey of military service members and veterans with non-muscle invasive bladder cancer, showing 53% were diagnosed at age 50 or younger and revealing barriers to care (Business Wire, 2026-11-11). The stock fell 6.17% to $6.26 on above-average volume (1.78x normal), though the survey is epidemiological rather than clinical trial data.
7d ago
Valuation
LQDA
Liquidia rallied 4.29% to $57.58 following a wave of analyst upgrades anchored by Raymond James' upgrade to Strong Buy with a $77 price target (raised from $53) and BTIG's hike to $87 (from $70), both citing robust Q3 results and resilient demand. Q3 revenues surged 314.9% year-over-year to $225.3M, driven by YUTREPIA pulmonary arterial hypertension drug sales of $222.7M, per Zacks earnings coverage. Volume of 523K shares remains below the 0.59x time-adjusted average.
7d ago
Risk
HWC
Hancock Whitney announced its acquisition of Trustmark Corporation via Business Wire and SEC 8-K filing today, triggering an 11.84% intraday decline from $72.38 to $63.81. Volume surged to 9.67x the time-adjusted historical average (1.43M shares in 70 minutes), reflecting heavy selling pressure on the deal news.
7d ago
Valuation
TWST
Twist Bioscience reported Q4 FY2026 revenue of $126.6 million, beating consensus estimates of $123–124 million, and achieved a profitability milestone with adjusted EBITDA of $2.2 million (per Business Wire and Zacks). However, management's initial fiscal 2027 guidance disappointed: organic growth projected at ~21% and AI drug discovery revenue at ~$100 million (~69% growth) fell short of prior "triple-digit order growth" expectations, and gross margin guidance of 52.5–53% trailed consensus. The stock fell 10.47% to $109.75 on elevated volume of 3.93x average, triggering a "sell the news" reaction despite the revenue beat.
7d ago
Valuation
SYM
Symbotic is trading down ~5.65% to $35.02 as investors weigh valuation and customer-concentration concerns following its expanded Walmart automation agreement, alongside cautious positioning ahead of its November 23 earnings report. While the multi-year ~$6 billion Walmart deal expands backlog, elevated forward multiples and heavy revenue dependence on a single customer are tempering enthusiasm. Recent analyst caution—including a Hold rating and $35 price target from Jefferies and a trimmed $43 target from Baird—has pressured near-term momentum.
7d ago
Risk
FPS
Forgent Power Solutions reported fiscal Q1 2027 results above the high end of guidance and raised full-year outlook, citing strong commercial and operational execution (Business Wire). Despite the positive earnings beat and raised outlook, FPS fell 6.23% intraday from $24.57 to $23.04 on elevated volume of 6.68M shares (2.33x expected for this stage of session), suggesting a sell-the-news reaction.
7d ago
Valuation
FRMI
Fermi announced a $200 million hyperscaler commitment for its Project Matador power development in Texas and terminated its TensorWave lease arrangement, per its Q3 2026 earnings report filed today and covered by Barron's. The stock surged 22.10% to $2.21 on volume of 47.6 million shares (5.86x normal for this time of day), despite a wider-than-expected Q3 net loss of $141.6 million (22¢/share vs. 8¢ consensus loss).
7d ago
Activity
BLTE
Belite Bio reported unaudited third-quarter 2026 financial results and provided a corporate update via Globe Newswire today, lifting the stock +6.84% to $166.60. Volume surged to 172,051 shares in the first 100 minutes, running 4.03x the historical average for this time of day, signaling strong investor interest in the earnings announcement.
7d ago
Material / Earnings
BLTE
Belite Bio, Inc (BLTE) reported EPS of −$0.60 vs. −$0.79 consensus estimate, beating expectations by 23.7%.
7d ago
Material / Earnings
FRMI
Fermi Inc. Common Stock (FRMI) reported EPS of −$0.22 vs. consensus estimate of −$0.04 for Q3 FY2026, missing by 463%.
7d ago
Valuation
SMCI
Super Micro Computer shares fell 12.68% to $26.57 on renewed concerns over potential China-related export-control violations and compliance issues with AI hardware diversion, per Benzinga reporting cited in market commentary. The decline coincides with broader tech-sector selling and profit-taking across Nasdaq peers. Volume surged to 47.3M shares, 3.37x the time-adjusted average, reflecting elevated institutional and retail exit activity.
7d ago
Risk
MSTR
Strategy (MSTR) fell 5.44% to $115.69 after MSCI confirmed the company's removal from its indexes, as reported by The Wall Street Journal and Benzinga. The exclusion threatens passive fund outflows given Strategy's status as the world's largest corporate Bitcoin holder. Volume of 12.9M shares ran at 1.01x the historical average for this time of session.
7d ago
Valuation
NVDA
NVIDIA CEO Jensen Huang resigned following board pressure amid reports of personal conduct issues, with interim replacement Colette Kress named to lead. The shock triggered a 5.69% intraday drop to $163.85 (down nearly 7% at the open per the web catalyst), with analyst downgrades—including Cantor Fitzgerald cutting price targets from $350 to $250—compounding the sell-off and threatening to shed hundreds of billions in market value.
7d ago
Activity
AVGO
Broadcom rallied 5.21% to $363.19 as investors rotated away from Nvidia toward rival chipmakers, according to Benzinga and Barron's reporting on Thursday. The move reflects broader semiconductor sector momentum tied to AI infrastructure spending, with Wall Street analysts having historically underestimated hyperscaler capex demand (Motley Fool).
7d ago
Valuation
CTVA
Corteva reported third-quarter earnings of $0.06 per share, missing consensus estimates of $0.10, and Q3 revenue of $1.59 billion below the $1.76–$1.77 billion expectation (Benzinga). Latin American organic sales plunged 31% due to severe headwinds in Brazil—elevated inventory, delayed farmer purchases, high interest rates, and tight farmer liquidity—while the company lowered full-year 2026 EBITDA guidance to approximately $1.1 billion amid pricing pressures and elevated R&D spending. CTVA fell 24.22% intraday from $12.14 to $9.20.
7d ago
Stocks tracked
986
Total changes
47854
Most active
MU
Avg 30D change
-0.01%

Educational research tool — not personalized investment advice. Data may be delayed.